Role of caveolin-eNOS platform and mitochondrial ATP-sensitive potassium channel in abrogated cardioprotective effect of ischemic preconditioning in postmenopausal women
DOI:
https://doi.org/10.1590/s2175-97902022e20081%20%20Keywords:
Caveolin, Nitric oxide, Mito KATP, Ischemic preconditioning, PostmenopauseAbstract
Caveolin, the protein of the caveolar membrane, interacts and binds with endothelial nitric oxide synthase (eNOS), forming a caveolin-eNOS complex leading to suppression of the eNOS activity. Caveolin, therefore, maintains eNOS in the inactivated state leading to reduced nitric oxide (NO) production. Ischemic preconditioning disrupts the caveolin-eNOS complex leading to activation of the eNOS and thus results in cardioprotection. During ischemic preconditioning, NO produces cardioprotection by the opening of the KATP channel, and the caveolin forms a suitable signalling platform facilitating the interaction of NO with the KATP channel. Estrogen deficiency has been reported to upregulate caveolin-1 expression. The article aims to review the various mechanisms that placed the women at the risk of coronary artery diseases after postmenopausal estrogen deficiency and their role in the cardioprotective effect of ischemic preconditioning.
Downloads
References
Abete P, Ferrara N, Cioppa A, Ferrara P, Bianco S, Calabrese C, et al. Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol. 1996;2(7):1777-86.
Aguilar-Bryan L, Clement JP, Gonzalez G, Kunjilwar K, Babenko A, Bryan J. Toward understanding the assembly and structure of KATP channels. Physiol Rev. 1998;78(1):227-45.
Ajmani P, Yadav HN, Singh M, Sharma PL. Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. BMC Cardiovasc Disord. 2011;11:43.
Ambrosio G, Tritto I. Reperfusion injury: Experimental evidence and clinical implications. Am Heart J. 1999;138(2 Pt 2):S69-75.
Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, Ward PA. Ischemia/reperfusion injury. J Surg Res. 2002;105(2):248-58.
Andreotti F, Pasceri V, Hackett DR, Davies GJ, Haider AW, Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med. 1996;334(1):7-12.
Andrukhiv A, Costa AD, West IC, Garlid KD. Opening mitoKATP increases superoxide generation from complex I of the electron transport chain. Am J Physiol Heart Circ Physiol. 2006;291(5):H2067-74.
Anzai T, Yoshikawa T, Asakura Y, Abe S, Akaishi M, Mitamura Het al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after first Q wave myocardial infarction. J Am Coll Cardiol . 1995;26(2):319-27.
Bae S, Zhang L. Gender Differences in Cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling. J Pharmacol Exp Ther. 2005;315(3):1125-35.
Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol. 1997;29(1):207-16.
Baines CP, Song CX, Zheng YT, Wang GW, Zhang J, Wang OL, et al. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res. 2003;92(8):873-80.
Baines CP. The Mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol. 2009;104(2):181-8.
Banerjee A, Locke-Winter C, Rogers KB, Mitchell MB, Brew EC, Cairns CB, et al. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an alpha 1-adrenergic mechanism. Circ Res . 1993;73(4):656-70.
Barrett-Connor E, Stuenkel C. Hormones and heart disease in women: Heart and Estrogen/Progestin replacement study in perspective. J Clin Endocrinol Metab. 1999;84(6):1848-53.
Barrett-Connor E. Sex differences in coronary heart disease: Why are women so superior? the 1995 Ancel Keys Lecture. Circulation. 1997;95(1):252-64.
Bartosz G. Reactive oxygen species: destroyers or messengers? BiochemPharmacol. 2009;77(8):1303-15
Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res. 2004;61(3):461-70.
Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasche, P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation . 1999;100:II340-4.
Bell SP, Sack MN, Patel A, Opie LH, Yellon DM. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol. 2000;36(7):2296-302.
Best PJ, Berger PB, Miller VM, Lerman A. The effect of estrogen a replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med. 1998;128(4):285-8.
Bolli R, Jeroudi MO, Patel BS, DuBose CM, Lai EK, Roberts R, et al. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci U S A. 1989;86(12):4695-9.
Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview. Basic Res Cardiol . 1996;91(1):57-63.
Bouwman RA, Musters RJ, van Beek-Harmsen BJ, de Lange JJ, Boer C. Reactive oxygen species precede protein kinase C-delta activation independent of adenosine triphosphate-sensitive mitochondrial channel opening in sevoflurane-induced cardioprotection. Anesthesiology. 2004;100(3):506-14.
Buja LM. Myocardial ischemia and reperfusion injury. Cardiovasc Pathol. 2005;14(4):170-5.
Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem. 1988;34(8B):B60-70.
Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation . 1987;75:1102-9.
Camper-Kirby D, Welch S, Walker A, Shiraishi I, Setchell KD, Schaefer E,et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ Res . 2001;88:1020-7.
Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, et al. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998;282(5392):1318-21.
Charan K, Goyal A, Gupta JK, Yadav HN. Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart. J Surg Res . 2016;201(2):272-8.
Chen M, Won DJ, Krajewski S, Gottlieb RA. Calpain and mitochondria in ischemia/reperfusion injury. J Biol Chem. 2002;277(32):29181-6.
Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest. 1999;103(3):401-6.
Clarkson TB, Cline JM, Williams JK, Anthony MS. Gonadal hormone substitutes: effects on cardiovascular system. Osteoporos Int. 1997;1:S43-51.
Cohen MV, Liu GS, Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation . 1991;84(1):341-9.
Cohen MV, Philipp S, Krieg T, Cui L, Kuno A, Solodushko V, et al. Preconditioning-mimetics Bradykinin and DADLE Activate PI3-Kinase Through Divergent Pathways. J Mol Cell Cardiol . 2007;42(4):842-51.
Collard CD and Gelman S. Pathophysiology, clinical manifestation, and prevention of ischemia-reperfusion injury. Anesthesiology . 2001;94(6):1133-8.
Costa AD, Garlid KD, West IC, Lincoln TM, Downey JM, Cohen MV, et al. Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res . 2005;97(4):329-36.
Costa AD, Jakob R, Costa CL, Andrukhiv K, West IC, Garlid KD. The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition. J Biol Chem . 2006;281(30):20801-8.
da Silva MM, Sartori A, Belisle E, Kowaltowski AJ. Ischemic preconditioning inhibits mitochondrial respiration, increases H2O2 release and enhances K+ Transport. Am J Physiol Heart Circ Physiol . 2003;285(1):H154-62.
Das M, Das S, Das DK. Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium.J Cell Mol Med. 2007;11(4):788-97.
Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA. Neutrophil-activating protein-1/interleukin-8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med. 1999;171(4):1155-62.
Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399(6736):601-5.
Diwan V, Kant R, Jaggi AS, Singh N, Singh D. Signal mechanism activated by erythropoietin preconditioning and remote renal preconditioning-induced cardioprotection. Mol Cell Biochem. 2008;315(1-2):195-201.
Downey JM, Cohen MV.Reducing infarct size in the setting of acute myocardial infarction. Prog Cardiovasc Dis. 2006;48(5):363-71.
Downey M, Cohen MV. Preconditioning: What it is and how it works. Dialogues in Cardiovascular Medicine. 1997;2:179-96.
Dreixler JC, Shaikh AR, Shenoy SK, Shen Y, Roth S. Protein kinase C subtypes and retinal ischemic preconditioning. Exp Eye Res.2008;87(4):300-11.
Dröse S, Brandt U, Hanley PJ. K+-independent actions of diazoxide question the role of inner membrane KATP channels in mitochondrial cytoprotective signaling. J Biol Chem . 2006;281(33):23733-9.
Du YH, Peng J, Huang ZZ, Jiang DJ, Deng HW, Li YJ. Delayed cardioprotection afforded by nitroglycerin is mediated by alpha-CGRP via activation of inducible nitric oxide synthase. Int J Cardiol. 2004;93(1):49-54.
Elçioglu KH, Kabasakal L, Cetinel S, Conturk G, Sezen SF, Ayanoğlu-Dülger G. Changes in caveolin -1 expression and vasoreactivity in the aorta and corpus cavernosum of fructose and streptozotocin-induced diabetic rats. Eur J Pharmacol. 2010;642(1-3):113-20.
Elimadi A, Sapena R, Settaf A, Le Louet H, Tillement J, Morin D. Attenuation of liver normothermic ischemia-reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative. Biochem Pharmacol . 2001;62(4):509-16.
Engelman JA, Zhang XL, Razani B, Pestell RG, Lisanti MP. p42/44 MAP kinase-dependent and-independent signaling pathways regulate caveolin-1 gene expression. Activation of Ras-MAP kinase and protein kinase a signaling cascades transcriptionally down-regulates caveolin-1 promoter activity. J Biol Chem . 1999;274(45):32333-41.
Ermak G, Davies KJ. Calcium and oxidative stress: from cell signaling to cell death. Mol Immunol. 2002;38(10):713-21.
Ferdinandy P, Schulz R and Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/ reperfusion injury, preconditioning and postconditioning. Pharmacol Rev. 2007;59(4):418-58.
Ferdinandy P, Szilvassy Z, Baxter GF. Adaptation to myocardial stress in disease states: is preconditioning a healthy heart phenomenon? Trends Pharmacol Sci. 1998;19(6):223-9.
Feron O, Balligand JL. Caveolin and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc Res . 2006;69(4):788-97.
Ford DA. Alterations in myocardial lipid metabolism during myocardial ischemia and reperfusion. Prog Lipid Res. 2002;41(1):6-26.
Fraser H, Davidge ST, Clanachan AS. Enhancement of post-ischemic myocardial function by chronic 17 beta-estradiol treatment: role of alterations in glucose metabolism. J Mol Cell Cardiol . 1999;31(8):1539-49.
Frassdorf J, Borowski A, Ebel D, Feindt P, Hermes M, Meemann Tet al. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery. J Thorac Cardiovasc Surg.2009;137(6):1436-42.
Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature . 1999;399(6736):597-601.
Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn’t calcium/calmodulin enough? J Pharmacol Exp Ther . 2001;299(3):818-24.
Galagudza MM, Blokhin IO, Shmonin AA, Mischenko KA. Reduction of Myocardial ischemia-reperfusion injury with pre-and postconditioning: molecular mechanism and therapeutic targets. Cardiovasc Hematol Disord Drug Targets. 2008;8(1):47-65.
Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex and t-tubule abnormalities. J Biol Chem . 2001;276(24):21425-33.
García-Cardeña G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem . 1997;272(41):25437-40.
Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D’Alonzo AJ, et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res . 1997;81(6):1072-82.
Gasser R, Schafhalter I, Wolff P, Schwarz T, Furschuss W, Klein W. Experimental models and definitions of myocardial ischemia: A review. Int J Angiol. 1994;3:154-6.
Gavin KM, Seals DR, Silver AE, Moreau KL. Vascular Endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women. J Clin Endocrinol Metab . 2009;94(9):3513-20.
Gho BC, Schoemaker RG, van den Doel MA, Duncker DJ, Verdouw PD. Myocardial protection by brief ischemia in noncardiac tissue. Circulation . 1996;94(9):2193-00.
Glenney JR Jr. Tyrosine Phosphorylation of a 22-kDa Protein is correlated with transformation by Rous sarcoma virus. J Biol Chem . 1989;264(34):20163-6.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation . 2013;127(1):e6-e245.
Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res . 1995;77(3):611-21.
Goyal A, Semwal BC, Yadav HN. Abrogated cardioprotective effect of ischemic preconditioning in ovariectomized rat heart. Hum Exp Toxicol. 2016;35(6):644-53.
Goyal A, Agrawal N. Ischemicpreconditioning:Interruptionof various disorders. J Saudi Heart Assoc. 2017;29(2):116-27.
Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al. Hormone therapy to prevent disease and prolong life in a postmenopausal women. Ann Intern Med . 1992;117(12):1016-37.
Gratton JP, Bernatchez P, Sessa WC. Caveolae and caveolins in the cardiovascular system. Circ Res . 2004;94(11):1408-17.
Gross GJ, Peart JN. KATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol . 2003;285(3):H921-30.
Grover GJ, D’Alonzo AJ, Parham CS, Darbenzio RB. Cardioprotection with the KATPopener cromakalim is not correlated with ischemic myocardial action potential duration. J Cardiovasc Pharmacol. 1995;26(1):145-52.
Gundewar S, Lefer DJ. Sphingolipid therapy in myocardial ischemia reperfusion injury. Biochim Biophys Acta. 2008;1780(3).571-6.
Gupta I, Goyal A, Singh NK, Yadav HN, Sharma PL. Hemin, a heme oxygenase-1 inducer, restores the attenuated cardioprotective effect of ischemic preconditioning in isolated diabetic rat heart. Hum Exp Toxicol . 2017;36(8):867-75.
Haider AW, Andreotti F, Hackett DR, Tousoulis D, Kluft C, Maseri A, et al. Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage. J Am Coll Cardiol . 1995;26(3):662-7.
Hale SL, Birnbaum Y, Kloner RA. beta-Estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J . 1996;132(2 Pt 1):258-62.
Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res . 2004;61(3):372-85.
Halestrap AP. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans. 2006;34(Pt 2):232-7.
Han S, Huang W, Liu Y, Pan S, Feng Z, Li S. Does leukocyte- depleted blood cardioplegia reduce myocardial reperfusion injury in cardiac surgery? A systematic review and meta- analysis. Perfusion. 2013;28(6):474-83.
Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischemia-reperfusion injury. Cardiovasc Res . 2003;60(3):617-25.
Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia- reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res . 2004;61(3):448-60.
Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M,et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res . 2000;87(8):677-82.
Head BP, Patel HH, Roth DM, Lai NC, Niesman IR, Farquhar MG, et al. G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem . 2005;280 (35):31036-44.
Hennan JK, Driscoll EM, Barrett TD, Fischbach PS, Lucchesi BR. Effect of sodium/hydrogen exchange inhibition on myocardial infarct size after coronary artery thrombosis and thrombolysis. Pharmacology. 2006;78(1):27-37.
Hide EJ, Thiemermann, C. Limitation of myocardial infarct size in the rabbit by ischaemic preconditioning is abolished by sodium 5-hydroxydecanoate. Cardiovasc Res . 1996;31(6):941-6.
Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, et al. Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem . 2001;276(5):3459-67.
Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Up regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 1995;36(3)0:291-3.
Honda HM, Korge P, Weiss JN. Mitochondria and ischemia/reperfusion injury. Ann N Y Acad Sci. 2005;1047:248-58.
Insel PA, Head BP, Patel HH, Roth DM, Bundey RA, Swaney JS. Compartmentation of G-protein coupled receptors and their signalling components in lipid rafts and caveolae. Biochem Soc Trans . 2005;33(Pt 5):1131-4.
Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP. Ischemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol. 2003;549(Pt 2):513-24.
Jonassen AK, Mjøs OD, Sack MN. p70S6 Kinase is a functional target of insulin activated Akt cell-survival signalling. Biochem Biophys Res Commun. 2004;315(1):160-5.
Joy M, Cairns AW, Sprigings D. Observations on the warm-up phenomenon in angina pectoris. Br Heart J. 1987;58(2):116-21.
Kato T, Kamiyama T, Maruyama Y, Tanaka S, Yoshimoto N. Nicorandil, a potent cardioprotective agent, reduces qt dispersion during coronary angioplasty. Am Heart J . 2001;141(6):940-3.
Khanna G, Diwan V, Singh M, Singh N, Jaggi AS. Reduction of ischemic, pharmacological and remote preconditioning effects by an antioxidant N-acetyl cysteine pretreatment in isolated rat heart.YakugakuZasshi. 2008;128(3):469-77.
Kis A, Yellon DM, Baxter GF. Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. J Mol Cell Cardiol . 2003;35(9):1063-71.
Kloner RA, Jennings RB. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation . 2001;104(24):2981-9.
Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, Yoo K, et al. Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation . 1998;97(11):1042-5.
Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol . 1993;21(2):537-45.
Kolodgie FD, Farb A, Litovsky SH, Narula J, Jeffers LA, Lee SJ, et al. Myocardial protection of contractile function after global ischemia by physiologic estrogen replacement in the ovariectomized rat. J Mol Cell Cardiol . 1997;29(9):2403-14.
Koneru S, Penumathsa SV, Thirunavukkarasu M, Samuel SM, Zhan L, Han Z, et al. Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4. Am J Physiol Heart Circ Physiol . 2007;292(5):H2060-72.
Korge P, Honda HM, Weiss JN.Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning. Proc Natl Acad Sci U S A . 2002;99(5):3312-7.
Krajewska WM, Masłowska I. Caveolins: Structure and function in signal transduction. Cell Mol Biol Lett. 2004;9(2):195-220.
Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol. 1998;60:619-42.
Kukreja RC, Salloum F, Das A, Ockaili R, Yin C, Bremer YA, et al. Pharmacological preconditioning with sildenafil: Basic mechanisms and clinical implications. VasculPharmacol. 2005;42(5-6):219-32.
Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res . 1993;72(6):1293-9.
Lawrence CL, Billups B, Rodrigo GC, Standen NB. The KATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation. Br J Pharmacol. 2001;134(3):535-42.
Lee TM, Su SF, Chou TF, Tsai CH. Pharmacologic preconditioning of estrogen by activation of the myocardial adenosine triphosphate-sensitive potassium channel in patients undergoing coronary angioplasty. J Am Coll Cardiol . 2002;39(5):871-7.
Leesar MA, Stoddard MF, Xuan YT, Tang XL, Bolli, R. Nonelectrocardiographic evidence that ischemic preconditioning and adenosine preconditioning exist in humans. J Am Coll Cardiol . 2003;42(3):437-45.
Levin RE. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol. 2005;19(8):1951-9.
Liao SL, Chen WY, Chen CJ. Estrogen attenuates tumor necrosis factor-alpha expression to provide ischemic neuroprotection in female rats. Neurosci Lett. 2002;330(2):159-62.
Liu A, Gao L, Kang S, Liu Y, Xu C, Sun H, et al. Testosterone enhances estradiol’scardioprotection in ovariectomized rats.J Endocrinol. 2011;11:1-34.
Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation . 1991;84(1):350-6.
Liu M, Zhang P, Chen M, Zhang W, Yu L, Yang XC et al. Aging might increase myocardial ischemia/reperfusion- induced apoptosis in humans and rats. Age (Dordr). 2012;34(3):621-32.
Lozza G, Conti A, Ongini E, Monopoli A. Cardioprotective effects of adenosine A1and A2A receptor agonists in the isolated rat heart. Pharmacol Res. 1997;35(1):57-64.
Machikas AM, Hunter JC, Lopez V, Korzick DH.Increased mitochondrial permeability transition pore opening dominates ischemia-reperfusion injury in the aged female rat heart. Circ Res . 2018;111:A342.
Maniatis NA, Brovkovych V, Allen SE, John TA, Shajahan AN, Tiruppathi C, et al. Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells. Circ Res . 2006;99(8):870-7.
Marber MS, Joy MD, Yellon DM. Is warm-up angina ischemic preconditioning. Br Heart J . 1994;72(3):213-5.
Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation . 1993;88(3):1264-72.
Marczak J, Nowicki R, Kulbacka J, Saczko J. Is remote ischaemic preconditioning of benefit to patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg. 2012;14(5):634-9.
Marczin N, El-Habashi N, Hoare GS, Bundy RE, Yacoub M. Antioxidants in myocardial ischemia-reperfusion injury: therapeutic potential and basic mechanisms. Arch Biochem Biophys. 2003;420(2):222-36.
Marina Prendes MG, González M, Savino EA, Varela A. Role of endogenous nitric oxide in classic preconditioning in rat hearts. Regul Pept. 2007;139(1-3):141-5.
McCabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain “calcium-independent” eNOS activation by phosphorylation. J Biol Chem . 2000;275(9):6123-8.
McCully JD, Levitsky S. The mitochondrial K(ATP) channel and cardioprotection. Ann Thorac Surg. 2003;75(2):S667-73.
Mentzer RM, Rahko PS, Molina-Viamonte V, Canver CC, Chopra PS, Love RB, et al. Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during coronary artery bypass surgery. Am J Cardiol. 1997;79(12A):38-43.
Michel JB, Feron O, Sacks D, Michel T. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem . 1997;272(25):15583-6.
Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet. 1998;18(4):365-8.
Minshall RD, Tiruppathi C, Vogel SM, Malik AB. Vesicle formation and traffickng in endothelial cells and regulation of endothelial barrier function. Histochem Cell Biol. 2002;117(2):105-12.
Mironova GD, Negoda AE, Marinov BS, Paucek P, Costa AD, Grigoriev SM et al. Functional distinctions between the mitochondrial ATP-dependent K+ channel (mito KATP) and its inward rectifier subunit (mito KIR). J Biol Chem . 2004;279(31):32562-8.
Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res . 1995:76(1):73-81.
Mocanu MM, Bell RM, Yellon DM. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol . 2002;34(6):661-8.
Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F, Pujia A. Endogenous testosterone and endothelial function in postmenopausal women. Coron Artery Dis. 2007;18(1):9-13.
Moukarbel GV, Ayoub CM, Abchee AB. Pharmacological therapy for myocardial reperfusion injury. Curr Opin Pharmacol. 2004;4(2):147-53.
Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008;88(2):581-609.
Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res . 2004;94(1):7-16.
Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation . 1986;74(5):1124-36.
Noma A. ATP-regulated K+ channels in cardiac muscle. Nature . 1983;305(5930):147-8.
Novgorodov SA, Gudz TI. Ceramide and mitochondria in ischemia/reperfusion. J Cardiovasc Pharmacol . 2009;53(3):198-208.
Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a Family of Scaffolding Proteins for Organizing “Preassembled Signalling Complexes” at the Plasma Membrane. J Biol Chem . 1998;273(10):5419-22.
Okazaki Y, Kodama K, Sato H, Kitakaze M, Hirayama A, Mishima M et al. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up phenomenon. J Am Coll Cardiol . 1993;21(7):1597-1604.
Oldenburg O, Qin Q, Sharma AR, Cohen MV, Downey JM, Benoit JN. Acetylcholine leads to free radical production dependent on K(ATP) channels, G(i) proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc Res . 2002;55(3):544-52.
Ostrom RS, Insel PA. The Evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol . 2004;143(2):235-45.
Pachauri P, Garabadu D, Goyal A, Upadhyay PK. Angiotensin (1-7) facilitates cardioprotection of ischemic preconditioning on ischemia-reperfusion-challenged rat heart. Mol Cell Biochem . 2017;430(1-2):99-113.
Palade GE. Fine structure of blood capillaries. J Appl Phys. 1953, 24:1424-36.
Parratt JR, Kane KA. KATP channels in ischaemic preconditioning. Cardiovasc Res . 1994;28(6):783-7.
Patel HH, Murray F, Insel PA. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol. 2008;48:359-91.
Patel HH, Tsutsumi YM, Head BP, Niesman IR, Jennings M, Horikawa Y, et al. Mechanisms of cardiac protection from ischemia/reperfusion injury:a role for caveolae and caveolin-1. FASEB J. 2007;21(7):1565-74.
Paz Y, Gurevitch J, Frolkis I, Matsa M, Kramer A, Locker C, et al. Effects of an angiotensin II antagonist on ischemic and nonischemic isolated rat hearts. Ann Thorac Surg . 1998;65(2):474-9.
Pelligrino DA, Ye S, Tan F, Santizo RA, Feinstein DL, Wang Q. Nitric-oxide-dependent pial arteriolar dilation in the female rat: effects of chronic estrogen depletion and repletion. Biochem Biophys Res Commun . 2000;269(1):165-71.
Penna C, Mancardi D, Rastaldo R, Losano G, Pagliaro P. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res . 2007;75(1):168-177.
Penna C, Mancardi D, Rastaldo R, Pagliaro P. Cardioprotection: a radical view Free radicals in pre and postconditioning. Biochim Biophys Acta . 2009;1787(7):781-93.
Ping P, Takano H, Zhang J, Tang XL, Qiu Y, Li RC, et al. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res . 1999;84(5):587-604.
Piper HM, Abdallah Y, Schäfer C. The first minutes of reperfusion: a window of opportunity for cardioprotection. Cardiovasc Res . 2004;61(3):365-71.
Powers SK, Murlasits Z, Wu M, Kavazis AN. Ischemia-reperfusion-induced cardiac injury: A brief review. Med Sci Sports Exerc. 2007;39(9):1529-36.
Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P.Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation . 1993;87(3):893-9.
Przyklenk K, Darling CE, Dickson EW, Whittaker P. Cardioprotection ‘outside the box’the evolving paradigm of remote preconditioning. Basic Res Cardiol . 2003;98(3):149-57.
Puddu PE, Garlid KD, Monti F, Iwashiro K, Picard S, Dawodu AA, et al. Bimakalim: A promising KATP Channel Activating Agent. Cardiovasc Drug Rev. 2006;18(1):25-46.
Quinlan CL, Costa AD, Costa CL, Pierre SV, Dos Santos P, Garlid KD. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mito KATP Am J Physiol Heart Circ Physiol . 2008;295(3):H953-61.
Ranki HJ, Budas GR, Crawford RM, Jovanovic A. Gender-specific difference in cardiac ATP-sensitive K+ channels. J Am Coll Cardiol . 2001;38(3):906-15.
Razani B, Lisanti MP. Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A. Am J Physiol Cell Physiol. 2001;281(4):C1241-50.
Riess ML, Stowe DF, Warltier DC. Cardiac pharmacological preconditioning with volatile anesthetics: from bench to bedside? Am J Physiol Heart Circ Physiol . 2004;286(5):H1603-7.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-33.
Roth TF, Porter KR. Yolk Protein Uptake in the oocyte of the mosquito aedes aegyti. J Cell Biol. 1964;20(2):313-32.
Santos CH, Gomes OM, Pontes JC, Miiji LN, Bispo MA. The ischemic preconditioning and postconditioning effect on the intestinal mucosa of rats undergoing mesenteric ischemia/ reperfusion procedure. Acta Cir Bras. 2008;23(1):22-8.
Sato T, O’Rourke B, Marbán E. Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. Circ Res . 1998;83(1):110-14.
Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, et al. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem . 1997;272(46):29337-46.
Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol . 1994;127(5):1233-43.
Schulman D, Latchman DS, Yellon DM. Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol . 2001:281(4);H1630-6.
Schultz JE, Rose E, Yao Z, Gross GJ. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol . 1995;268(5 Pt 2):H2157-61.
Schulz R, Rose J, Heusch G. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol . 1994;267(4 Pt 2):H1341-52.
Segawa D, Sjöquist PO, Wang QD, Gonon A, Nordlander M, Rydén L. Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipine. J Cardiovasc Pharmacol . 2000;36(3):338-43.
Sharma S, Singh M, Sharma PL. Beneficial effect of insulin in hyperhomocysteinemia and diabetes mellitus induced vascular endothelium dysfunction: role of phosphoinositide dependent kinase and protein kinase B. Mol Cell Biochem . 2011;348:21-32.
Shaul PW, Anderson RG. Role of plasmalemmal caveolae in signal transduction. Am J Physiol . 1998;275(5):L843-51.
Shinmura K, Nagai M, Tamaki K, Bolli R. Loss of ischemic preconditioning in ovariectomized rat hearts: possible involvement of impaired protein kinase C epsilon phosphorylation. Cardiovasc Res . 2008;79(3):387-94.
Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature . 2000;407(6803):538-41.
Sisakiyan H. Pathophysiology, clinical significance and possibilities of cardioprotection in myocardial stunning, hibernation and preconditioning. New Am Med J. 2008;2:28-34.
Skyschally A, Gres P, Heusch P, Martin C, Haude M, Erbel R, et al. Preinfarction angina: no interference of coronary microembolization with acute ischemic preconditioning. J Mol Cell Cardiol . 2005;39(2):355-61.
Snoeckx LH, van der Vusse GJ, Coumans WA, Willemsen PH, Reneman RS. Differences in ischaemia tolerance between hypertrophied hearts of adult and aged spontaneously hypertensive rats. Cardiovasc Res . 1993;27(5):874-81.
Snoeckx LH, van der Vusse GJ, Coumans WA, Willemsen PH, van der Nagel T, Reneman RS. Myocardial function in normal and spontaneously hypertensive rats during reperfusion after a period of global ischemia. Cardiovasc Res .1986;20(1):67-75.
Solaini G, Harris DA. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J. 2005;390(Pt 2):377-394.
Song KS, Li Shengwen, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem . 1996;271(16):9690-7.
Spieker LE, Lüscher TF, Noll G. Current Strategies and perspectives for correcting endothelial dysfunction in atherosclerosis. J Cardiovasc Pharmacol . 2001;38:S35-41.
Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the nurses’ health study. N Engl J Med . 1991;325(11):756-62.
Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med . 1985;313(17):1044-9.
Sullivan JM, Vander Zwaag R, Lemp GF, Hughes JP, Maddock V, Kroetz FW, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med . 1998;108(3):358-63.
Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, et al. Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest . 2002;109(4):509-16.
Szocs K. Endothelial Dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrite tolerance. Gen Physiol Biophys. 2004;23(3):265-95.
Takano H, Tang XL, Qiu Y, Guo Y, French BA, Bolli R. Nitric Oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res . 1998;83(1):73-84.
Tang WH, Wu S, Wong TM, Chung SK, Chung SS. Polyol pathway mediates iron-induced oxidative injury in ischemic- reperfused rat heart. Free Radic Biol Med. 2008;45(5):602-10.
Tanonaka K, Taguchi T, Koshimizu M, Ando T, Morinaka T, Yogo T, et al. Role of an ATP-sensitive potassium channel opener, YM934, in mitochondrial energy production in ischemic/reperfused heart. J Pharmacol Exp Ther . 1999;291(2):710-6.
Thornton JD, Daly JF, Cohen MV, Yang XM, Downey JM Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ Res . 1993;73(4):649-55.
Timmers L, Henriques JP, de Kleijn DP, Devries JH, Kemperman H, Steendijk P, et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol . 2009;53(6):501-10.
Tomai F, Crea F, Chiariello L, Gioffrè PA. Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation . 1999;100(5):559-63.
Tomoda H, Aoki N. Comparison of protective effects of preinfarction angina pectoris in acute myocardial infarction treated by thrombolysis versus primary coronary angioplasty with stenting. Am J Cardiol . 1999;84(6):621-5.
Tong H, Chen W, Steenbergen C, Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res . 2000;87(4):309-15.
Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective. Circ Res . 2002;90(4):377-9.
Tong H, Rockman HA, Koch WJ, Steenbergen C, Murphy E. G protein coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning. Circ Res . 2004;94(8):1133-41.
Tsutsumi YM, Horikawa YT, Jennings MM, Kidd MW, Niesman IR, Yokoyama U, et al. Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning. Circulation . 2008;118(19):1979-88.
Tyagi P, Tayal G. Ischemic preconditioning of the myocardium. Acta Pharmacol Sin. 2002;23(2):865-70.
Vanden Hoek TL, Becker LB, Shao Z, Li C, Schumacker PT.Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J Biol Chem . 1998;273(29):18092-8.
Varshney V, Goyal A, Gupta JK, Yadav HN. Role of erythropoietin in ischemic postconditioning induced cardioprotection in hyperlipidemic rat heart. J Indian College Cardiol. 2017;7:72-7.
Walker DM, Marber MS, Walker JM, Yellon DM. Preconditioning in isolated superfused rabbit papillary muscles. Am J Physiol . 1994;266(4 Pt 2):H1534-40.
Walsh SR, Tang T, Sadat U, Dutka DP, Gaunt ME. Cardioprotection by remote ischemic preconditioning. Br J Anaesth. 2007;99(5):611-6.
Wang X, Abdel-Rahman AA. Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts. Am J Physiol Heart Circ Physiol . 2002;282(6):H2309-15.
Weiland U, Haendeler J, Ihling C, Albus U, Scholz W, Ruetten H, et al. Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cardiovasc Res . 2000;45(3):671-8.
Williams TM, Lisanti MP. The caveolin genes: from cell biology to medicine. Ann Med. 2004;36(8):584-95.
Woolfson RG, Patel VC, Neild GH, Yellon DM. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation . 1995;91(5):1545-51.
Xu B, Zhu GH, Weng JF, Cai WS, Xia JT, Li SH. The roles of caveolin-1and endothelial nitric oxide synthase in the development of portal hypertension in rats with liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2008;16(3):184-7.
Xu Y, Arenas IA, Armstrong SJ, Plahta WC, Xu H, Davidge ST. Estrogen improves cardiac recovery after ischemia/ reperfusion by decreasing tumor necrosis factor-alpha. Cardiovasc Res . 2006;69(4):836-44.
Yadav HN, Singh M, Sharma PL. Involvement of GSK-3β in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart. Mol Cell Biochem . 2010a;343(1-2):75-81.
Yadav HN, Singh M, Sharma PL. Modulation of cardioprotective effect of ischemic preconditioning in hyperlipidaemic rat heart. Eur J Pharmacol . 2010b;643(1):78-83.
Yadav HN, Varshney V, Singh NK, Sharma PL. Quercetin: a phytoestrogen attenuate GSK-3b inhibitors induced delayed cardioprotection in diabetic rat heart. Pharmacologia. 2015;6:293-9.
Yamada E. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol. 1955;1(5):445-58.
Yan H, Song L, Yang J, Sun Y, Hu D. The association between pre-infarction angina and care-seeking behaviors and its effects on early reperfusion rates for acute myocardial infarction. Int J Cardiol . 2009;135(1):86-92.
Yang MK, Lee SH, Seo HW, Yi KY, Yoo SE, Lee BH, et al. KR-31761, a novel K+(ATP) channel opener, exerts cardioprotective effects by opening both Mitochondrial K+(ATP) and sarcolemmal K+(ATP) channels in rat models of ischemia/reperfusion-induced heart injury. J Pharmacol Sci. 2009;109(2):222-32.
Yao Z, Gross GJ. A Comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels. Circulation . 1994;89(3):1229-36.
Yao Z, Gross GJ. Role of nitric oxide, muscarinic receptors, and the ATP-sensitive K+ channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res . 1993;73(6):1193-201.
Yellon DM, Baxter GF. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart. 2000;83(4):381-7.
Yellon DM, Downey JM. Preconditioning the myocardium from cellular physiology to clinical cardiology. Physiol Rev .2003;83(4):1113-5.
Ylitalo K, Niemela M, Linnaluoto M, Valkama J, Mattila K, Peuhkurinen K. Evidence suggesting coronary vasodilatation as the principal mechanism in the warm-up phenomenon. Am Heart J . 2001;141:5A-12A.
Ylitalo K, Peuhkurinen K. Adaptation to myocardial ischemia during repeated ventricular pacing in patients with coronary artery disease. Scand Cardiovasc J. 2000;34(2):134-41.
Yokoshiki H, Sunagawa M, Seki T, Sperelakis N. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol . 1998;274(1):C25-37.
Yoshida H, Kusama Y, Kodani E, Yasutake M, Takano H, Atarashi H et al. Pharmacological preconditioning with bradykinin affords myocardial protection through NO-dependent mechanisms. Int Heart J. 2005;46(5):877-87.
Young LH, Ikeda Y, Lefer AM. Caveolin-1 peptide exert cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism. Am J Physiol Heart Circ Physiol . 2001;280(6):H2489-95.
Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol . 1994;266(3 Pt 2):H1145-52.
Zong WX, Thompson CB.Necrotic death as a cell fate. Genes Dev. 2006;20(1):1-15.
Zoratti M, De Marchi U, Gulbins E, Szabo I. Novel channels of the inner mitochondrial membrane. Biochim Biophys Acta . 2009;1787(5):351-63.
Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 1997;90(3):405-13.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
